Scholarly Index
Kozo Nakamura
Towa Pharmaceutical (Japan); 35,601 total citations; 727 total publications; best world rank #134
Towa Pharmaceutical (Japan)
35,601Total citations
727Total publications
98H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Spinal Fractures and Fixation Techniques | Lifetime | 256 | JP 22 | 98.80 |
| Spine and Intervertebral Disc Pathology | Lifetime | 572 | JP 70 | 98.31 |
| Connective tissue disorders research | Lifetime | 183 | JP 7 | 97.38 |
| Cervical and Thoracic Myelopathy | Lifetime | 161 | JP 28 | 97.88 |
| Scoliosis diagnosis and treatment | Lifetime | 188 | JP 13 | 97.64 |
| Bone health and treatments | Lifetime | 511 | JP 33 | 97.68 |
| Bone Metabolism and Diseases | Lifetime | 351 | JP 35 | 97.69 |
| GABA and Rice Research | Lifetime | 294 | JP 29 | 96.86 |
| Osteoarthritis Treatment and Mechanisms | Lifetime | 726 | JP 44 | 96.95 |
| Fibroblast Growth Factor Research | Lifetime | 724 | JP 69 | 91.88 |
| Heterotopic Ossification and Related Conditions | Lifetime | 134 | JP 17 | 91.04 |
| Freezing and Crystallization Processes | Lifetime | 999 | JP 77 | 82.10 |
| GABA and Rice Research | 2021-2025 | 820 | JP 19 | 74.50 |